# A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma

> **NCT00949702** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 132 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** vemurafenib

## Key facts

- **NCT ID:** NCT00949702
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-30
- **Primary completion:** 2010-09-27
- **Final completion:** 2014-06-03
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949702, "A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00949702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*